EzriCare Lawsuit [2026 Update] | Artificial Tears Recall

In late December 2024, Alcon Laboratories issued a voluntary recall of one lot of Systane Lubricant Eye Drops Ultra PF due to potential fungal contamination, according to the U.S. Food and Drug Administration (FDA).

The affected product, sold in 25-count boxes nationwide both in stores and online, bears lot number 10101 with an expiration date of September 2025.

The recall follows a consumer complaint reporting foreign material in a sealed vial, later identified as fungal in nature.

While no adverse events have been reported yet, fungal contamination in eye drops can lead to severe eye infections, partial or total blindness, and, in rare cases, life-threatening complications for immunocompromised individuals.

Consumers are advised to:

• Stop using the product immediately if it matches the recalled lot.
• Return it to the place of purchase for a refund or replacement.
• Seek medical attention if experiencing any eye-related issues after using the drops.

This recall comes after similar concerns in the artificial tears market, including contaminated products linked to multiple deaths and vision loss last year.

The FDA continues to monitor and address these safety risks.

If you or a loved one used Artificial Tears, or other recalled products included in the recall, and subsequently experienced vision loss, eye infection, or other injuries, you may be eligible to file an Artificial Tears Lawsuit claim.

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify in under two minutes.

The EzriCare Artificial Tears lawsuit revolves around the contamination of eye drops that resulted in severe bacterial infections.

A key factor in this issue is the FDA’s backlog of factory inspections, particularly in high-priority regions like Asia.

Due to the pandemic, FDA inspections dropped by nearly 40%, leaving many plants, including those producing critical medications, without oversight. Concerns about drug shortages have limited the FDA’s ability to act swiftly on violations.

Moreover, the agency’s current inspection approach—primarily focused on physical inspections—has been criticized for not adequately detecting quality issues.

Experts like Dr. Kevin Schulman suggests that U.S. pharmacy chains should purchase from higher-quality manufacturers to mitigate risks like those seen in the EzriCare case.

If you or a loved one used EzriCare Artificial Tears, Delsam Artificial Tears, or other products included in the recall, and subsequently experienced vision loss, eye infection, or other injuries, you may be eligible to file an EzriCare Artificial Tears Lawsuit claim.

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify in under two minutes.

Several brands of artificial tears and eye drops have been recalled in the past year due to bacterial contamination in manufacturing facilities abroad.

These recalls followed a Food and Drug Administration (FDA) inspection that raised questions about the sterility of these products

EzriCare was the first and most prominent artificial tears brand identified as potentially containing Bacterium Pseudomonas Aeruginosa.

Eye-care products have a higher risk of physical harm because they’re applied directly to the eye, which means they can bypass some of the body’s natural defenses against contaminants.

Manufacturing and storing eyedrops in a sterile way is also difficult.

Contaminated eye products pose serious risks, including infections that could lead to severe, potentially life-threatening conditions.

In February 2023, a recall involving contaminated eye-care products was associated with 14 cases of vision loss and four fatalities, with some patients requiring surgical intervention to remove their eyes

The recalls have largely involved over-the-counter eye drops and ointments, including “copycat” eye drops, which are designed to look like common brands but haven’t been approved by the F.D.A. and sometimes carry misleading health claims

Lawsuits are still being filed against EzriCare and other companies whose products were contaminated with dangerous bacteria.

If you or a loved one have used any recalled brands of artificial tears or eyedrops and are experiencing symptoms, it is essential to collect the following evidence for potential legal claims:

• Medical records
• The artificial tears you used
• Receipts of purchase for recalled products
• Any other documentation proving your use of recalled artificial tears and subsequent health problems

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page for an instant case evaluation.

The FDA has recently alerted consumers about the dangers of unapproved eye drops  sold online, including brands like South Moon, Rebright, and FivFivGo, due to the risk of eye infections.

These products, which are marketed for conditions such as glaucoma, are raising concerns about consumer health and safety.

This warning comes amid no reported adverse events from these brands, but there have been reports of potentially counterfeit products causing issues such as eye irritation, pain, and infection.

In a related development, Brassica Pharma has voluntarily recalled four eye ointment products after FDA inspections raised sterility concerns.

The recalled products, including two under Walmart’s Equate brand and others from CVS Health and AACE Pharmaceuticals, highlight an ongoing concern with eye safety.

The recall spans products with expiration dates from February 2024 to September 2025.

This action follows a series of recalls affecting 27 eye drop products from various retailers, sparked by risks of infection leading to vision loss or even blindness.

A February 2023 warning against EzriCare and Delsam Pharma’s Artificial Tears linked these products to an outbreak of drug-resistant bacteria, affecting 81 patients with serious outcomes, including vision loss, surgical eyeball removal, and death.

Consumers are urged to stop using the recalled ointments and any of the implicated eye drops, to dispose of them properly, or to return them where they were purchased.

Contact our Lawyers for a free consultation, or use the chatbot on this page to find out if you qualify to file an Artificial Tears claim instantly.

The investigation linked a multistate outbreak of drug-resistant Pseudomonas aeruginosa infections to EzriCare Artificial Tears.

The outbreak, spanning 18 states with 81 confirmed cases, has been traced back to EzriCare Artificial Tears.

Pseudomonas aeruginosa is a type of bacteria commonly found in the environment, and in people with weakened immune systems or with wounds, the bacteria can cause severe infections.

The Pseudomonas aeruginosa germ is known for being resistant to many antibiotics, making said infections difficult to treat.

Whole Genome Sequencing (WGS) was used to trace the outbreak back to the EzriCare Artificial Tears outbreak.

WGS is a process that determines the complete DNA sequence of an organism’s genome at a single time, essentially taking a detailed photo of all the genes in a germ to see its complete DNA “blueprint.”

Scientists use this “photo” to see if germs from different people match up, helping to figure out if there’s a common source for an infection.

In the case of the EzriCare Artificial Tears outbreak, scientists used WGS to analyze the DNA of the Pseudomonas aeruginosa bacteria that was isolated from patients who used the artificial tears.

By comparing these sequences researchers found that the bacterial strains were closely related to each other, indicating a common source of infection.

Several civil lawsuits have been filed against EzriCare and Delsam Pharma, the companies behind the artificial tears, by individuals who faced severe health complications due to the drug-resistant nature of the bacteria.

These health complications include 14 individuals experiencing permanent vision loss, four undergoing surgical removal of an eyeball, and four fatalities.

The CDC advises discontinuing the use of EzriCare Artificial Tears and seeking medical care if symptoms of an eye infection are present.

The FDA recall status for the products remains active, urging consumers not to use these products.

If you or a loved one have suffered infections or injuries after using contaminated EzriCare Eyedrops, you may be eligible to file a lawsuit. 

Contact TorHoerman Law or use the chatbot on this page to find out if you qualify for the EzriCare Lawsuit instantly.

On August 22nd, the FDA released a new warning urging vendors and consumers to stop selling and using two additional types of artificial tear drops.

The two types of eyedrops are Dr. Berne’s MSM Drops 5% Solution and LightEyez MSM Eye Drops, and they are believed to be contaminated with bacteria and or fungi.

In part of its statement, the FDA said it conducted sampling and testing of these products and found that they both are contaminated with microbes and are not sterile.

As of September 9th, the FDA has not received any reports of these additional eye drop types causing injury, however, they continue to warn that the risk of injury from using these products is high.

If you used EzriCare or Delsam eye drops and subsequently suffered from eye pain, injury, or infection you may be eligible to file an EzriCare Eye Drops Lawsuit.

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify for a EzriCare Eye Drops Lawsuit instantly.

On February 9th, 2023, a Florida woman filed a lawsuit against EzriCare artificial tears, citing a resistant bacterial infection that caused her unrelenting pain after using the eye drops.

This came a week after EzriCare issued a nationwide recall due to possible bacterial contamination of Pseudomonas aeruginosa in their eye drops.

Since that first lawsuit was filed, the CDC has registered 81 cases across 18 states of infections caused by EzriCare eye drops.

Delsam has also issued recalls for contaminated eye drops — Delsam distributes eye drops from the same manufacturer as EzriCare.

Out of these 81 infections, there have been four deaths, four cases of eyeballs being surgically removed, and 14 cases of vision loss.

Symptoms of possible infection typically include, but are not limited to:

• Yellow, green or clear discharge from the eye;
• Eye or eyelid redness;
• The sensation of something being in the eye;
• Increased sensitivity to light; or
• Blurry vision

In April of this year, an FDA inspection of the facility where the EzriCare and Delsam eye drops are produced concluded that the manufacturing process lacked measures to ensure product sterility, specifically in product batches that were produced between December 2020 and April 2022.

Some of their findings showed that the water filtration system was not fully functioning and that the airflow in the factory’s aseptic cleaning rooms were limited.

Both of these instances can create conditions that allow bacteria to flourish.

This lawsuit is still in early pre-trial stages, and new cases of infection are still being discovered.

If you used EzriCare or Delsam eye drops and subsequently suffered from eye pain, injury, or infection you may be eligible to file an EzriCare Artificial Tears Lawsuit.

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify for a EzriCare Artificial Tears Lawsuit instantly.